Related references
Note: Only part of the references are listed.Transplantation for Acute Liver Failure in Patients Exposed to NSAIDs or Paracetamol (Acetaminophen) The Multinational Case-Population SALT Study
Sinem Ezgi Gulmez et al.
DRUG SAFETY (2013)
Choice of the denominator in case population studies: event rates for registration for liver transplantation after exposure to NSAIDs in the SALT study in France
Nicholas Moore et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2013)
Myocardial infarction and individual nonsteroidal anti-inflammatory drugs meta-analysis of observational studies
Cristina Varas-Lorenzo et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2013)
Insulin glargine and risk of cancer: a cohort study in the French National Healthcare Insurance Database
P. Blin et al.
DIABETOLOGIA (2012)
Validity of chronic drug exposure presumed from repeated patient interviews varied according to drug class
Pernelle Noize et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2012)
Cardiovascular and Gastrointestinal Safety of NSAIDs: A Systematic Review of Meta-Analyses of Randomized Clinical Trials
F. Salvo et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Stroke risk and NSAIDs: a systematic review of observational studies
Cristina Varas-Lorenzo et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2011)
Cardiovascular Risk with Non-Steroidal Anti-Inflammatory Drugs: Systematic Review of Population-Based Controlled Observational Studies
Patricia McGettigan et al.
PLOS MEDICINE (2011)
Hospitalizations for gastrointestinal and cardiovascular events in the CADEUS cohort of traditional or Coxib NSAID users
David Laharie et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Pharmacoepidemiological research using French reimbursement databases: yes we can!
Karin Martin-Latry et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2010)
Comparison of health insurance claims and patient interviews in assessing drug use: data from the Three-City (3C) Study
Pernelle Noize et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2009)
Role of Dose Potency in the Prediction of Risk of Myocardial Infarction Associated With Nonsteroidal Anti-Inflammatory Drugs in the General Population
Luis Alberto Garcia Rodriguez et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
The pattern of use of non-steroidal anti.-inflammatory drugs (NSAIDs) from 1997 to 2005: a nationwide study on 4.6 million people
Emil Loldrup Fosbol et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2008)
Channelling of COX-2 inhibitors to patients at higher gastrointestinal risk but not at lower cardiovascular risk:: the Cox2 inhibitors and tNSAIDs description of users (CADEUS) study
F. Depont et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2007)
The CADEUS study:: methods and logistics
F. Depont et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2007)
Quantitative assessment of the gastrointestinal and cardiovascular risk-benefit of celecoxib compared to individual NSAIDs at the population level
Cristina Varas-Lorenzo et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2007)
Risk of upper gastrointestinal complications among users of traditional NSAIDs and COXIBs in the general population
Luis A. Garcia Rodriguez et al.
GASTROENTEROLOGY (2007)
Meta-analysis: Cardiovascular events associated with nonsteroidal anti-inflammatory drugs
Shelley R. Salpeter et al.
AMERICAN JOURNAL OF MEDICINE (2006)
Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials
Patricia M. Kearney et al.
BMJ-BRITISH MEDICAL JOURNAL (2006)
Non-steroidal antiinflammatory drugs and the risk of acute myocardial infarction
S Hernández-Díaz et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2006)
How and why are non-prescription analgesics used in Scotland?
T Porteous et al.
FAMILY PRACTICE (2005)
NSAID use profiles derived from reimbursement data in France
N Moore et al.
THERAPIE (2004)
Nonsteroidal antiinflammatory drugs and the risk of myocardial infarction in the general population
LAG Rodríguez et al.
CIRCULATION (2004)
The use of non-prescription medicines by general practitioner attendees
G Urquhart et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2004)
Effects of nabumetone, celecoxib, and ibuprofen on blood pressure control in hypertensive patients on angiotensin converting enzyme inhibitors
R Palmer et al.
AMERICAN JOURNAL OF HYPERTENSION (2003)
Pharmacovigilance of over-the-counter products based in community pharmacy: methodological issues from pilot work conducted in Hampshire and Grampian, UK
D Layton et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2002)
Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis.
C Bombardier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis - The CLASS study: A randomized controlled trial
FE Silverstein et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Quantitative estimation of rare adverse events which follow a biological progression: a new model applied to chronic NSAID use
MR Tramer et al.
PAIN (2000)
Share Paper
